Literature DB >> 23358705

Performance of coralline hydroxyapatite in sinus floor augmentation: a retrospective study.

Zhi-Bin Luo1, Qing-Bin Zhang, Zhao-Qiang Zhang, Dan Chen, Wang-Xiang Yan, Ke-Feng Li, Yu Chen.   

Abstract

OBJECTIVE: The purpose of this study is to retrospectively explore the utilization of coralline hydroxyapatite in maxillary sinus augmentation.
METHOD: One hundred and eighteen cases of sinus lift with coralline hydroxyapatite (CHA) were included in this study. In detail, simultaneous implantation was conducted in 78 patients (174 implants) and delayed implantation was done in 40 cases (82 implants) around 6 months after bone transplantation. The clinical features and X-ray radiographs after operation were analyzed to evaluate osseointegration procedures according to a planned medical follow-up. In the delayed group, around 6 months, a bone biopsy was taken just during implant placement in order to evaluate the new formed bone from a histological and histomorphometrical point of view. A further 6 months later, abutment connection was performed, and the patients received prosthetic restoration of the missing teeth. RESULT: Clinically, the incisions healed well. No abnormal reactions were found during follow-up period. All the 174 simultaneous implants were successful after 1-5 years of medical review; Out of 82 delayed implants, 3 were found to be loose. Histologically, all the specimens showed signs of active remodeling, and all the tissues had a large amount of osteocyte at sixth month after sinus augmentation. New bone formed dramatically. Radiologically, the density of CHA gradually reduced since the beginning of the third month, and CHA may be completely resolved at about fifth year.
CONCLUSION: CHA is proven an ideal bone graft material for its reliable clinical results and favorable histocompatibility in the treatment of sinus atrophy or other kinds of insufficient bone volume in this region. Moreover, CHA's signal application can achieve desired clinical effect. CLINICAL RELEVANCE: This study shows the clinic application of CHA in maxillary sinus augmentation. Compared with popular mixture of autogenous bone and grafting materials, our results show CHA's signal application can achieve ideal osseointegration interface and satisfying clinic effect.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358705     DOI: 10.1007/s00784-013-0922-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  36 in total

1.  A new sinus lift technique in conjunction with placement of 265 implants: a 6-year retrospective study.

Authors:  F Cosci; M Luccioli
Journal:  Implant Dent       Date:  2000       Impact factor: 2.454

2.  Sinusfloor elevation and grafting with autogenous iliac crest bone.

Authors:  J P van den Bergh; C M ten Bruggenkate; G Krekeler; D B Tuinzing
Journal:  Clin Oral Implants Res       Date:  1998-12       Impact factor: 5.977

3.  Sinus floor elevation using a bovine bone mineral (Bio-Oss) with or without the concomitant use of a bilayered collagen barrier (Bio-Gide): a clinical report of immediate and delayed implant placement.

Authors:  G Tawil; M Mawla
Journal:  Int J Oral Maxillofac Implants       Date:  2001 Sep-Oct       Impact factor: 2.804

4.  Impact of implant surface and grafting protocol on clinical outcomes of endosseous implants.

Authors:  Claudio Marchetti; Francesco Pieri; Stefano Trasarti; Giuseppe Corinaldesi; Marco Degidi
Journal:  Int J Oral Maxillofac Implants       Date:  2007 May-Jun       Impact factor: 2.804

5.  The biologic behavior of hydroxyapatite implanted into the maxillofacial skeleton.

Authors:  H M Rosen; M M McFarland
Journal:  Plast Reconstr Surg       Date:  1990-05       Impact factor: 4.730

6.  Maxillary sinus augmentation using an engineered porous hydroxyapatite: a clinical, histological, and transmission electron microscopy study in man.

Authors:  Carlo Mangano; Antonio Scarano; Giovanna Iezzi; Giovanna Orsini; Vittoria Perrotti; Francesco Mangano; Sergio Montini; Marcello Piccirilli; Adriano Piattelli
Journal:  J Oral Implantol       Date:  2006       Impact factor: 1.779

7.  Bone formation and implant degradation of coralline porous ceramics placed in bone and ectopic sites.

Authors:  S Pollick; E C Shors; R E Holmes; R A Kraut
Journal:  J Oral Maxillofac Surg       Date:  1995-08       Impact factor: 1.895

8.  Maxillary sinus grafting for totally and partially edentulous patients.

Authors:  M S Block; J N Kent
Journal:  J Am Dent Assoc       Date:  1993-05       Impact factor: 3.634

Review 9.  Sinus augmentation. Rationale, development, long-term results.

Authors:  O H Tatum; M S Lebowitz; C A Tatum; R A Borgner
Journal:  N Y State Dent J       Date:  1993-05

Review 10.  Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement?

Authors:  Tara L Aghaloo; Peter K Moy
Journal:  Int J Oral Maxillofac Implants       Date:  2007       Impact factor: 2.804

View more
  3 in total

1.  New Horizons for Hydroxyapatite Supported by DXA Assessment-A Preliminary Study.

Authors:  Jakub Litak; Cezary Grochowski; Andrzej Rysak; Marek Mazurek; Tomasz Blicharski; Piotr Kamieniak; Piotr Wolszczak; Mansur Rahnama-Hezavah; Grzegorz Litak
Journal:  Materials (Basel)       Date:  2022-01-26       Impact factor: 3.623

2.  Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair.

Authors:  Mônica Diuana Calasans-Maia; Bruno Raposo de Melo; Adriana Terezinha Neves Novellino Alves; Rodrigo Figueiredo de Brito Resende; Rafael Seabra Louro; Suelen Cristina Sartoretto; José Mauro Granjeiro; Gutemberg Gomes Alves
Journal:  J Appl Oral Sci       Date:  2015 Nov-Dec       Impact factor: 2.698

3.  Nanosized hydroxyapatite and β-tricalcium phosphate composite: Physico-chemical, cytotoxicity, morphological properties and in vivo trial.

Authors:  Igor da Silva Brum; Jorge José de Carvalho; Jorge Luis da Silva Pires; Marco Antonio Alencar de Carvalho; Luiza Braga Ferreira Dos Santos; Carlos Nelson Elias
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.